Cumberland Pharmaceuticals CPIX Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's accounts receivable?
- Cumberland Pharmaceuticals (CPIX) reported accounts receivable of $14.26M in Q1 2026.
- How has Cumberland Pharmaceuticals's accounts receivable changed year-over-year?
- Cumberland Pharmaceuticals's accounts receivable increased by 36.0% year-over-year, from $10.49M to $14.26M.
- What is the long-term trend for Cumberland Pharmaceuticals's accounts receivable?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's accounts receivable has grown at a 6.5% compound annual growth rate (CAGR), from $12.38M to $16.94M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.